Hing C. Wong

Hing C. Wong publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hing C. Wong sits on this spectrum.

Hing C. Wong D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hing C. Wong sits on this spectrum.

Best Publications

• Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

  Li Tang;Yiran Zheng;Mariane Bandeira de Melo;Llian Mabardi

  615
  Citations

• T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation

  Sarah E Henrickson;Thorsten R Mempel;Irina B Mazo;Bai Liu

  504
  Citations

• A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.

  Kimberlyn F. Card;Shari A. Price-Schiavi;Bai Liu;Elizabeth Thomson

  484
  Citations

• ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

  John M Wrangle;Vamsidhar Velcheti;Manish R Patel;Elizabeth Garrett-Mayer

  426
  Citations

• First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

  Rizwan Romee;Sarah Cooley;Melissa M. Berrien-Elliott;Peter Westervelt

  411
  Citations

• CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

  Julia A. Wagner;Maximillian Rosario;Rizwan Romee;Melissa M. Berrien-Elliott

  320
  Citations

• IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization

  Unknown

  301
  Citations

• Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor αSu/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma

  Unknown

  263
  Citations

• Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

  Peter R. Rhode;Jack O. Egan;Wenxin Xu;Hao Hong

  228
  Citations

• Structural basis of the recognition of the dishevelled DEP domain in the Wnt signaling pathway.

  Hing C. Wong;Junhao Mao;Jason T. Nguyen;Shamala Srinivas

  214
  Citations

• Novel human interleukin-15 agonists.

  Unknown

  211
  Citations

• Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

  Szu Han Huang;Yanqin Ren;Allison S. Thomas;Dora Chan

  201
  Citations

• Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors.

  Kim Margolin;Chihiro Morishima;Chihiro Morishima;Vamsidhar Velcheti;Jeffrey S. Miller

  200
  Citations

• IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas

  Peter S. Kim;Anna R. Kwilas;Wenxin Xu;Sarah Alter

  188
  Citations

• A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.

  R. Brad Jones;R. Brad Jones;Stefanie Mueller;Rachel O’Connor;Katherine Rimpel

  187
  Citations

• IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.

  M. Felices;S. Chu;B. Kodal;L. Bendzick

  160
  Citations

• The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and in Vivo Clearance of B Cell Lymphomas

  Maximillian Rosario;Bai Liu;Lin Kong;Lynne I. Collins

  156
  Citations

• Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

  Unknown

  143
  Citations

• Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+ T Cells Is Directly Associated with the Magnitude of Surface IgG Binding

  Adjoa Smalls-Mantey;Nicole Doria-Rose;Rachel Klein;Andy Patamawenu

  143
  Citations

• Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control

  Annelise Y. Mah;Armin Rashidi;Molly P. Keppel;Nermina Saucier

  125
  Citations